Literature DB >> 35027748

Omicron thwarts some of the world's most-used COVID vaccines.

Elie Dolgin.   

Abstract

Entities:  

Keywords:  Immunology; Medical research; Public health; SARS-CoV-2; Vaccines; Virology

Mesh：

Substances：

Year:  2022        PMID： 35027748     DOI： 10.1038/d41586-022-00079-6

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.

Authors:  Lu Lu; Bobo Wing Yee Mok; Lin Lei Chen; Jacky Man Chun Chan; Owen Tak Yin Tsang; Bosco Hoi Shiu Lam; Vivien Wai Man Chuang; Allen Wing Ho Chu; Wan Mui Chan; Jonathan Daniel Ip; Brian Pui Chun Chan; Ruiqi Zhang; Cyril Chik Yan Yip; Vincent Chi Chung Cheng; Kwok Hung Chan; Dong Yan Jin; Ivan Fan Ngai Hung; Kwok Yung Yuen; Honglin Chen; Kelvin Kai Wang To
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999
  1 in total
  16 in total

1.  Humoral and cellular immune responses to CoronaVac assessed up to one year after vaccination.

Authors:  Priscilla Ramos Costa; Carolina Argondizo Correia; Mariana Prado Marmorato; Juliana Zanatta de Carvalho Dias; Mateus Vailant Thomazella; Amanda Cabral da Silva; Ana Carolina Soares de Oliveira; Arianne Fagotti Gusmão; Lilian Ferrari; Angela Carvalho Freitas; Elizabeth González Patiño; Alba Grifoni; Daniela Weiskopf; Alessandro Sette; Rami Scharf; Esper Georges Kallas; Cássia Gisele Terrassani Silveira
Journal:  medRxiv       Date:  2022-07-07

2.  Analytic modeling and risk assessment of aerial transmission of SARS-CoV-2 virus through vaping expirations in shared micro-environments.

Authors:  Roberto A Sussman; Eliana Golberstein; Riccardo Polosa
Journal:  Environ Sci Pollut Res Int       Date:  2022-06-27       Impact factor: 5.190

3.  Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy.

Authors:  Zsolt Matula; Márton Gönczi; Gabriella Bekő; Béla Kádár; Éva Ajzner; Ferenc Uher; István Vályi-Nagy
Journal:  Vaccines (Basel)       Date:  2022-03-30

4.  Pre-existing antibody levels negatively correlate with antibody titers after a single dose of BBV152 vaccination.

Authors:  Suman Das; Janmejay Singh; Heena Shaman; Balwant Singh; Anbalagan Anantharaj; Patil Sharanabasava; Rajesh Pandey; Rakesh Lodha; Anil Kumar Pandey; Guruprasad R Medigeshi
Journal:  Nat Commun       Date:  2022-06-15       Impact factor: 17.694

5.  Heterologous ChAdOx1-BNT162b2 vaccination in Korean cohort induces robust immune and antibody responses that includes Omicron.

Authors:  Hye Kyung Lee; Jinyoung Go; Heungsup Sung; Seong Who Kim; Mary Walter; Ludwig Knabl; Priscilla A Furth; Lothar Hennighausen; Jin Won Huh
Journal:  iScience       Date:  2022-05-26

6.  Genetic differentiation and diversity of SARS-CoV-2 Omicron variant in its early outbreak.

Authors:  Shenghui Weng; Jingzhe Shang; Yexiao Cheng; Hangyu Zhou; Chengyang Ji; Rong Yang; Aiping Wu
Journal:  Biosaf Health       Date:  2022-04-25

7.  Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study.

Authors:  Anish Nag; Ritesh Banerjee; Subhabrata Paul; Rita Kundu
Journal:  Comput Biol Med       Date:  2022-04-27       Impact factor: 6.698

Review 8.  Strategies and safety considerations of booster vaccination in COVID-19.

Authors:  Hanyan Meng; Jianhua Mao; Qing Ye
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

9.  Healthcare Workers' Knowledge and Perception of the SARS-CoV-2 Omicron Variant: A Multinational Cross-Sectional Study.

Authors:  Akshaya Srikanth Bhagavathula; Mohammadjavad Ashrafi Mahabadi; Wubshet Tesfaye; Kesavan Rajasekharan Nayar; Vijay Kumar Chattu
Journal:  Healthcare (Basel)       Date:  2022-02-25

10.  Successive Pandemic Waves with Different Virulent Strains and the Effects of Vaccination for SARS-CoV-2.

Authors:  Alcides Castro E Silva; Américo Tristão Bernardes; Eduardo Augusto Gonçalves Barbosa; Igor Aparecido Santana das Chagas; Wesley Dáttilo; Alexandre Barbosa Reis; Sérvio Pontes Ribeiro
Journal:  Vaccines (Basel)       Date:  2022-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.